Our response to NICE’s decision not to recommend lenacapavir as PrEP
Last Updated:Our response to the National Institute for Health and Care Excellence (NICE) decision not to recommend lenacapavir as PrEP.
Our response to the National Institute for Health and Care Excellence (NICE) decision not to recommend lenacapavir as PrEP.
National AIDS Trust warns UK's 2030 HIV targets are at risk without cross-government action.
Our response to news that Grindr have paid £26m to settle UK lawsuit over allegedly sharing users' HIV status:
A new report highlights action that is now needed from the Welsh Government to tackle inequalities and further improve the quality of life for people living with HIV.
Discriminatory bar on same sex people with HIV donating sperm or eggs scrapped
We are extremely concerned to see media reporting which wilfully misrepresents the statistics and fuels racist and anti-migrant sentiment
We are deeply disappointed by the decision not to recommend CAB-LA as an HIV prevention option.
Urgent action is now needed to expand access to testing and reach people not in care